What do you mean by drugs outside the medical insurance catalogue?

Drugs outside the medical insurance catalogue refer to drugs that are not in the national medical insurance catalogue and cannot be reimbursed through medical insurance. These drugs usually need to be purchased by patients at their own expense, and the price is higher. Unlike medical insurance drugs, these drugs need to bear more economic pressure. In addition, drugs outside the medical insurance catalogue are not restricted by the medical insurance payment standard, and medical institutions will not supervise the quality and safety of such drugs.

Drugs listed in the national medical insurance catalogue after evaluation are guaranteed in terms of price, efficacy and safety. However, with the continuous emergence and research and development of new drugs, the medical insurance catalogue can not be updated in time, and many drugs that have been widely used in clinic before new drugs are included may appear outside the medical insurance catalogue. In addition, some high-end, high-tech drugs are expensive, and some companies have not reported to the national medical insurance department, so they will also be regarded as drugs outside the medical insurance catalogue.

What are the effects of drugs outside the medical insurance catalogue on people?

Drugs outside the medical insurance list are usually expensive. For some special diseases or patients, it is necessary to use these drugs for a long time, which will bring great pressure to the economic burden of patients. In real life, the treatment of some diseases requires the use of drugs outside the medical insurance catalogue, and these drugs are often high-tech and high-end preparations, which can have a positive impact on the treatment of patients. Therefore, we need to pay more attention to drugs outside the medical insurance catalogue, and at the same time give play to the role of the market mechanism to effectively protect people's health.